Cargando…
Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin
The luteinizing hormone-releasing hormone/androgen receptor (LHRH/AR) pathway is a promising treatment target in a subgroup of female patients with triple-negative breast cancer (TNBC). However, very little is known about the efficacy of this strategy in male patients with TNBC. In this report, we d...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438837/ https://www.ncbi.nlm.nih.gov/pubmed/30941241 http://dx.doi.org/10.4048/jbc.2019.22.e2 |